Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/165133
Registo completo
Campo DCValorIdioma
dc.creatorMartínez-Ciarpaglini, C-
dc.creatorBarros, R-
dc.creatorCaballero, C-
dc.creatorBoggino, H-
dc.creatorAlarcón-Molero, L-
dc.creatorPeleteiro, B-
dc.creatorRuiz-García, E-
dc.creatorFernandez-Figueroa, E-
dc.creatorHerrera-Goepfert, R-
dc.creatorDíaz-Romero, C-
dc.creatorFerreira, R-
dc.creatorGroen-van Schooten, TS-
dc.creatorGauna, C-
dc.creatorPereira, R-
dc.creatorCantero, D-
dc.creatorLezcano, H-
dc.creatorEsteso, F-
dc.creatorO Connor, J-
dc.creatorRiquelme, A-
dc.creatorOwen, G-
dc.creatorGarrido, M-
dc.creatorRoa, JC-
dc.creatorRuiz-Pace, F-
dc.creatorVivancos, A-
dc.creatorDiez-García, M-
dc.creatorAlsina, M-
dc.creatorMatito, J-
dc.creatorMartin, A-
dc.creatorGómez, M-
dc.creatorCastillo, E-
dc.creatorVila, M-
dc.creatorSantos-Antunes, J-
dc.creatorCosta, A-
dc.creatorLordick, F-
dc.creatorFarrés, J-
dc.creatorPalomar-De Lucas, B-
dc.creatorCabeza-Segura, M-
dc.creatorVillagrasa, R-
dc.creatorJimenez-Martí, E-
dc.creatorMiralles-Marco, A-
dc.creatorDienstmann, R-
dc.creatorDerks, S-
dc.creatorFigueiredo, C-
dc.creatorCervantes, A-
dc.creatorCarneiro, F-
dc.creatorFleitas-Kanonnikoff, T-
dc.date.accessioned2025-02-04T17:04:12Z-
dc.date.available2025-02-04T17:04:12Z-
dc.date.issued2025-
dc.identifier.issn1436-3305-
dc.identifier.issn1436-3291-
dc.identifier.urihttps://hdl.handle.net/10216/165133-
dc.description.abstract"Introduction: Gastric cancer (GC) burden is currently evolving with regional differences associated with complex behavioural, environmental, and genetic risk factors. The LEGACy study is a Horizon 2020-funded multi-institutional research project conducted prospectively to provide comprehensive data on the tumour biological characteristics of gastroesophageal cancer from European and LATAM countries. Material and methods: Treatment-naïve advanced gastroesophageal adenocarcinoma patients were prospectively recruited in seven European and LATAM countries. Formalin-fixed paraffin-embedded primary tumour endoscopic biopsy samples were collected and submitted for central morphological and immunohistochemical characterization and TP53 molecular assessment and Helicobacter pylori infection. Results: A total of 259 patients were included in the study: 137 (53%) from LATAM and 122 (47%) from Europe. Significant biological differences were detected between European and LATAM patients. Low representation of chromosomal instability (CIN) and HER2 positive cases were found in LATAM. MUC6 and PD-L1 were more frequently overexpressed in European cases, showing a significant correlation across the entire study population, with this association being especially pronounced in MMRdeficient cases. Both TP53 mutation by next-generation sequencing and p53 immunohistochemical aberrant pattern were linked with features associated with chromosomal instability. No regional differences were observed in H. pylori prevalence or abundance, indicating that the afore mentioned variations cannot be attributed to this factor. Conclusion: Our findings underscore a need for region-specific approaches in gastroesophageal cancer diagnosis and treatment. MUC6 emerges as a putative immune regulator that needs further investigation. Research tailored to the unique biological profiles in different global regions is crucial to effectively address the observed disparities."pt_PT
dc.description.sponsorshipThis study was funded by the European Union’s Horizon 2020 research and innovation program (Grant agreement No GA825832). The European Union was not involved in the collection, analysis and interpretation of data, in writing future manuscripts or in deciding to submit manuscripts for publication. This work was supported in Chile by ANID-FONDAP-152220002 & 15130011 (1523A0008), PROGRAMA ICM-ANID, ICN2021_045, and ANID FONDECYT 1220586. FONDECYT 1230504 (AR, GL, JCR) «Role of the genomic and microbiome profile in gastric carcinogenesis: prospective endoscopic follow-up», ANID FONDAP 152220002 (AR) «CECAN: Center for Cancer Prevention and Control”. The funding for Mexico was supported by CONAHCyTN°297681 (CELAC and European Consortium for Personalized Medicine Approach to Gastric Cancer (LEGACy).pt_PT
dc.language.isoengpt_PT
dc.publisherSpringerpt_PT
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/825832/EUpt_PT
dc.relation.ispartofGastric Cancer. 2025 Mar;28(2):160-173. doi: 10.1007/s10120-024-01578-3. Epub 2025 Jan 5.-
dc.rightsopenAccesspt_PT
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.titleComprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expressionpt_PT
dc.typeArtigo em Revista Científica Internacionalpt_PT
dc.contributor.uportoInstituto de Saúde Públicapt_PT
dc.identifier.doi10.1007/s10120-024-01578-3-
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s10120-024-01578-3-
Aparece nas coleções:ISPUP - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
martinezciarpaglini2025.pdf9.03 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons